N

Novel-plus

C
CAUTION
25
Total CVEs
0
Crit / High
2
Medium
16%
Unpatched
0%
Patched
4.2
Avg CVSS
0
CISA KEV
// Data sourced from NVD · CISA KEV · RHSA · GHSA · Debian · OSV · EPSS · Exploit-DB How we collect data →
// INTEL UPGRADE
Full Company Dossier — Coming Soon
Executive profiles, financial exposure, M&A risk, breach history & supply-chain threat mapping — all in one place.
OSINT FINANCIALS EXEC PROFILES BREACH DB
▸ CVE Trend by Year
▸ Patch Coverage
Patched
0%
Unpatched
16%
Under Review
28%
Pending
56%
✓ 0 patched ✗ 4 unpatched ~ 7 under review ⏳ 14 pending score
▸ Intelligence by Audience
PoC Available
12 / 20 shown
CISA KEV (Exploited)
0
Top EPSS (Exploitation Probability)
CVE-2025-45890 1.56% exploitation probability
CVE-2025-4018 0.76% exploitation probability
CVE-2025-4015 0.76% exploitation probability
CVE-2024-33383 0.67% exploitation probability
CVE-2025-4019 0.66% exploitation probability
Quick Facts for Reporting
Total CVEs tracked
25
Critical severity
0
Actively exploited (CISA)
0
Unpatched ratio
16%
Avg CVSS score
4.2
Security grade
C (CAUTION)
NVD Data Attribution
Source: NIST National Vulnerability Database (NVD) + GitHub Advisory Database.
Data aggregated by Valters IT Hub · valtersit.com
Last updated: 2026-08-03
Security Risk Score (for investors)
LOW
Vuln Volume
GOOD
Patch Responsiveness
LOW
CISA Exposure
⚠ Not financial advice. Past security incidents do not guarantee future stock performance.
▸ Recent CVEs showing 20 of 25
CVE IDSeverityPatchEPSSDate
CVE-2025-60299 PoC ? N/A UNKNOWN / UNPATCHED 0.03% 2025-10-08
CVE-2025-60298 PoC ? N/A UNKNOWN / UNPATCHED 0.03% 2025-10-08
CVE-2025-45890 ? N/A PATCH UNDER REVIEW 1.56% 2025-06-20
CVE-2025-4019 6.9 MEDIUM PATCH UNDER REVIEW 0.66% 2025-04-28
CVE-2025-4018 6.9 MEDIUM PATCH UNDER REVIEW 0.76% 2025-04-28
CVE-2025-4017 5.3 MEDIUM UNKNOWN / UNPATCHED 0.51% 2025-04-28
CVE-2025-4016 5.3 MEDIUM PATCH UNDER REVIEW 0.47% 2025-04-28
CVE-2025-4015 6.9 MEDIUM PATCH UNDER REVIEW 0.76% 2025-04-28
CVE-2024-33383 7.5 HIGH UNKNOWN / UNPATCHED 0.67% 2024-04-30
CVE-2024-25274 PoC ? N/A UNKNOWN / UNPATCHED 0.24% 2024-02-20
CVE-2024-24025 PoC ? N/A UNKNOWN / UNPATCHED 0.10% 2024-02-08
CVE-2024-24014 PoC ? N/A UNKNOWN / UNPATCHED 0.09% 2024-02-08
CVE-2024-24026 PoC ? N/A UNKNOWN / UNPATCHED 0.10% 2024-02-08
CVE-2024-24024 PoC ? N/A UNKNOWN / UNPATCHED 0.10% 2024-02-08
CVE-2024-24021 PoC ? N/A UNKNOWN / UNPATCHED 0.09% 2024-02-08
CVE-2024-24017 PoC ? N/A UNKNOWN / UNPATCHED 0.06% 2024-02-08
CVE-2024-24023 PoC ? N/A UNKNOWN / UNPATCHED 0.07% 2024-02-08
CVE-2024-24018 ? N/A UNKNOWN / UNPATCHED 0.61% 2024-02-08
CVE-2024-24019 PoC ? N/A UNKNOWN / UNPATCHED 0.07% 2024-02-07
CVE-2024-24015 PoC ? N/A UNKNOWN / UNPATCHED 0.07% 2024-02-06
View all 25 CVEs for Novel-plus →
▸Intel
Trust ScoreC — CAUTION
Max CVSS5.5
Last Updated2026-08-03
▸Company Profile

Novel-plus is a software vendor that develops and maintains the Novel-Plus content management system (CMS), which is used for creating and managing digital publications and websites. The company's products are primarily utilized in the publishing and media industries, and its cybersecurity relevance stems from the 23 CVEs tracked against its software, indicating a history of security vulnerabilities that could affect users of its CMS platform.

▸Response Metrics
Est. MTTR ⓘ ~500 days (Critical)
Mean Time To Remediate. Estimates days from CVE disclosure to patch.
Industry avg: ~60d (good) · 100-300d (poor) · 300d+ (critical)
CVE Trend ⓘ ↘ -47% better
CVE count 2025 vs 2024:  15 → 8 CVEs
Patch Speed ⓘ Poor (>65% open)
16% of CVEs still unpatched.  Excellent: <20% · Good: 20-40% · Avg: 40-65% · Poor: >65%
▸ Financial Risk Estimate
Est. GDPR Low
€600K
Est. GDPR High
€6.0M

Based on 0 critical CVEs, 0 CISA KEV, 100% unpatched. Model: GDPR Art.83 · not legal advice.

▸Actions
⚖ Compare with another vendor
▸Embed Badge
Novel-plus C valtersit.com